An FDA-approved GHRH analog used for HIV-associated lipodystrophy and visceral fat reduction.

A mitochondrial-derived peptide discussed for metabolic resilience and exercise-adjacent effects.

MOTS-c is resurfacing as a mitochondria-linked metabolism signal, framed more as energy and insulin sensitivity than appetite control.